Aprogen Healthcare & Games Inc (109960) - Total Liabilities

Latest as of September 2025: ₩15.37 Billion KRW ≈ $10.42 Million USD

Based on the latest financial reports, Aprogen Healthcare & Games Inc (109960) has total liabilities worth ₩15.37 Billion KRW (≈ $10.42 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Aprogen Healthcare & Games Inc - Total Liabilities Trend (2013–2024)

This chart illustrates how Aprogen Healthcare & Games Inc's total liabilities have evolved over time, based on quarterly financial data. See Aprogen Healthcare & Games Inc (109960) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Aprogen Healthcare & Games Inc Competitors by Total Liabilities

The table below lists competitors of Aprogen Healthcare & Games Inc ranked by their total liabilities.

Company Country Total Liabilities
Khon Kaen Sugar Industry PCL
BK:KSL
Thailand ฿27.03 Billion
Commerce.com, Inc.
NASDAQ:CMRC
USA $277.38 Million
Banco Hipotecario SA
BA:BHIP
Argentina AR$3.14 Trillion
Insecticides (India) Limited
NSE:INSECTICID
India Rs7.94 Billion
Beacon Minerals Limited
AU:BCN
Australia AU$55.83 Million
Icelandic Salmon As
OL:ISLAX
Norway Nkr153.36 Million
Etteplan Oyj
HE:ETTE
Finland €181.83 Million

Liability Composition Analysis (2013–2024)

This chart breaks down Aprogen Healthcare & Games Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 109960 stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 4.20 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.05 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.05 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Aprogen Healthcare & Games Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Aprogen Healthcare & Games Inc (2013–2024)

The table below shows the annual total liabilities of Aprogen Healthcare & Games Inc from 2013 to 2024.

Year Total Liabilities Change
2024-12-31 ₩33.08 Billion
≈ $22.42 Million
+12.94%
2023-12-31 ₩29.29 Billion
≈ $19.85 Million
+101.92%
2022-12-31 ₩14.51 Billion
≈ $9.83 Million
+251.58%
2021-12-31 ₩4.13 Billion
≈ $2.80 Million
-18.44%
2020-12-31 ₩5.06 Billion
≈ $3.43 Million
-35.68%
2019-12-31 ₩7.87 Billion
≈ $5.33 Million
-61.58%
2018-12-31 ₩20.47 Billion
≈ $13.87 Million
-24.01%
2017-12-31 ₩26.94 Billion
≈ $18.26 Million
+286.60%
2016-12-31 ₩6.97 Billion
≈ $4.72 Million
-42.09%
2015-12-31 ₩12.03 Billion
≈ $8.15 Million
+56.12%
2013-12-31 ₩7.71 Billion
≈ $5.22 Million
--

About Aprogen Healthcare & Games Inc

KQ:109960 Korea Pharmaceuticals
Market Cap
$216.77 Million
₩319.86 Billion KRW
Market Cap Rank
#16319 Global
#580 in Korea
Share Price
₩1790.00
Change (1 day)
-1.10%
52-Week Range
₩150.00 - ₩2300.00
All Time High
₩20250.00
About

Aprogen Healthcare & Games Inc. engages in the development of medicines using biomedical technology. The company operates through Game Business, Rental Profit, and Pharmaceutical divisions. It offers specialty drugs, such as antibiotics, circulatory system, digestive system, anti-inflammatory, and analgesic drugs. The company also offers wireless remote lighting monitoring and control system for … Read more